Skip to content

2026 EMWA Autumn Conference-Virtual

Nov 9-21,2026
Online (Live Webinar)

EMWA Autumn 2026 62nd Conference banner, 9-21 November 2026, virtual, with illustrated immune cells

Event: 2026 EMWA Autumn Conference-Virtual

Date: Nov 9-21,2026

Location: Online (Live Webinar)

The EMWA Autumn Conference 2026 is a fully virtual event hosted live on Zoom from November 9-21, bringing together medical writers and professionals from across the world. Spanning 45 sessions across nearly two weeks, the programme covers workshops, themed talks and panels, and expert discussion groups on topics including AI, medical communications, and regulatory writing, alongside free sessions open to all registrants. Content is designed for every career stage, from those new to medical writing to seasoned professionals, with sessions delivered live and recordings available afterward. Registration is open to EMWA members, with a one-off €50 fee covering the opening session and plenary before individual sessions can be booked. All times are shown in CET, and full payment is due by October 30, 2026. It's a flexible, accessible way to build skills, exchange ideas, and connect with the wider medical writing community without travel.


Presentation from AlphaLife Sciences:

Date: Nov 12
Time: 12:40–13:20 PM CET

Speaker:
-Nicola Haycock, Medical Writing Project Director, AlphaLife Sciences

-Viktor Fási, AI Product Manager Head, AlphaLife Sciences
Topic:  AI-Assisted Medical Writing That Holds Up to Review


Who it is for

Medical writers, regulatory writers and medical writing leads in pharma, biotech and CROs who prepare clinical and submission documents. If you have tried AI on a draft and found that it read well but left you with more to verify, or if you have not tried it yet and want to know how it might change your day-to-day work, this session is for you. No experience with AI tools is needed. Leads who set up documents and manage review rounds, and anyone who has to sign off on an AI-assisted draft, will find it directly relevant.


What it covers

How soon a document reaches finalisation often depends on review: how much you and your reviewers have to resolve, and how aligned the team are ahead of document sign-off. Review often takes longer than drafting. Using AI to generate a first draft much faster than before is a real gain, but it can add to the review burden: every sentence must be checked against its source. The aim is to ease that burden within your existing SOPs. In this session, we follow one clinical document from set-up to finalisation. At each stage you will see where AI can help and where the writer decides: a template, source list and key messages proposed for the lead to confirm; a draft showing the source behind each statement, gaps flagged rather than filled; specialist AI reviewers that can check the draft before your colleagues do, with evidence for each finding and a writer deciding how to respond; all comments in one list, conflicts flagged for you to resolve; and, when final tables arrive, targeted updates shown as tracked changes for you to accept or defer. Sign-off stays in your document management system, with a record of who changed what. We then explore six responsibilities that remain yours, from setting the key messages to presenting unwelcome data honestly and resolving disagreements between reviewers; the skills to build now; what regulators expect; and five things to try on Monday. AI can help with the sentences. The writer decides what the document presents.


To request a meeting, fill out the form provided and a representative will be in contact soon to schedule.


Schedule a Meeting with Us

By submitting this form, I accept to receive communications from AlphaLife Sciences in accordance with the Terms of our Privacy Policy

Thank You!

Thank you for requesting a meeting with our team! A representative will be in contact soon to schedule a convenient time.

View More Events